| Wellness Care Medical Group A Professional Corporation | |
|
416 16th Ave San Francisco CA 94118-2812 | |
| (415) 221-0177 | |
| Not Available |
| Full Name | Wellness Care Medical Group A Professional Corporation |
|---|---|
| Speciality | Internal Medicine |
| Location | 416 16th Ave, San Francisco, California |
| Authorized Official Name and Position | Maribeth Salvatin (MANAGER) |
| Authorized Official Contact | 4152210177 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Wellness Care Medical Group A Professional Corporation 416 16th Ave San Francisco CA 94118-2812 Ph: (415) 221-0177 | Wellness Care Medical Group A Professional Corporation 416 16th Ave San Francisco CA 94118-2812 Ph: (415) 221-0177 |
| NPI Number | 1194898726 |
|---|---|
| Provider Enumeration Date | 11/15/2006 |
| Last Update Date | 01/24/2018 |
| Medicare PECOS PAC ID | 5991773228 |
|---|---|
| Medicare Enrollment ID | O20040930000762 |
News Archive
Biologists at New York University have uncovered one way that biological clocks control neuronal activity - a discovery that sheds new light on sleep-wake cycles and offers potential new directions for research into therapies to address sleep disorders and jetlag.
Research scientists will develop "Facebook Light" - with a user interface suitable for the elderly and people with dementia - to promote important social contact.
A new study, VERIFY (Vildagliptin Efficacy in combination with metfoRmIn For earlY treatment of type 2 diabetes) presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Barcelona, Spain (16-20 Sept, 2019), and published simultaneously in The Lancet, is the first to show that early combination therapy using vildagliptin and metformin in patients newly diagnosed with type 2 diabetes (T2D) leads to better long-term blood sugar control and a reduced rate of treatment failure than metformin alone.
Researchers from the Molecular Biology Institute of Barcelona and the Institute of Biotechnology and Biomedicine have discovered the mechanism by which the bacterium Mycoplasma genitalium) adheres to human cells.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194898726 | NPI | - | NPPES |
| 1194898726 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (* (Not Available)) | Primary |
| Provider Name | Lee T Chan |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1992728414 PECOS PAC ID: 5092784637 Enrollment ID: I20040929001143 |
News Archive
Biologists at New York University have uncovered one way that biological clocks control neuronal activity - a discovery that sheds new light on sleep-wake cycles and offers potential new directions for research into therapies to address sleep disorders and jetlag.
Research scientists will develop "Facebook Light" - with a user interface suitable for the elderly and people with dementia - to promote important social contact.
A new study, VERIFY (Vildagliptin Efficacy in combination with metfoRmIn For earlY treatment of type 2 diabetes) presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Barcelona, Spain (16-20 Sept, 2019), and published simultaneously in The Lancet, is the first to show that early combination therapy using vildagliptin and metformin in patients newly diagnosed with type 2 diabetes (T2D) leads to better long-term blood sugar control and a reduced rate of treatment failure than metformin alone.
Researchers from the Molecular Biology Institute of Barcelona and the Institute of Biotechnology and Biomedicine have discovered the mechanism by which the bacterium Mycoplasma genitalium) adheres to human cells.
› Verified 2 days ago
| Provider Name | Yong Liu |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1316137987 PECOS PAC ID: 3274692751 Enrollment ID: I20081113000097 |
News Archive
Biologists at New York University have uncovered one way that biological clocks control neuronal activity - a discovery that sheds new light on sleep-wake cycles and offers potential new directions for research into therapies to address sleep disorders and jetlag.
Research scientists will develop "Facebook Light" - with a user interface suitable for the elderly and people with dementia - to promote important social contact.
A new study, VERIFY (Vildagliptin Efficacy in combination with metfoRmIn For earlY treatment of type 2 diabetes) presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Barcelona, Spain (16-20 Sept, 2019), and published simultaneously in The Lancet, is the first to show that early combination therapy using vildagliptin and metformin in patients newly diagnosed with type 2 diabetes (T2D) leads to better long-term blood sugar control and a reduced rate of treatment failure than metformin alone.
Researchers from the Molecular Biology Institute of Barcelona and the Institute of Biotechnology and Biomedicine have discovered the mechanism by which the bacterium Mycoplasma genitalium) adheres to human cells.
› Verified 2 days ago
| Provider Name | Wei Rao |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1245676360 PECOS PAC ID: 3072738384 Enrollment ID: I20140630001234 |
News Archive
Biologists at New York University have uncovered one way that biological clocks control neuronal activity - a discovery that sheds new light on sleep-wake cycles and offers potential new directions for research into therapies to address sleep disorders and jetlag.
Research scientists will develop "Facebook Light" - with a user interface suitable for the elderly and people with dementia - to promote important social contact.
A new study, VERIFY (Vildagliptin Efficacy in combination with metfoRmIn For earlY treatment of type 2 diabetes) presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Barcelona, Spain (16-20 Sept, 2019), and published simultaneously in The Lancet, is the first to show that early combination therapy using vildagliptin and metformin in patients newly diagnosed with type 2 diabetes (T2D) leads to better long-term blood sugar control and a reduced rate of treatment failure than metformin alone.
Researchers from the Molecular Biology Institute of Barcelona and the Institute of Biotechnology and Biomedicine have discovered the mechanism by which the bacterium Mycoplasma genitalium) adheres to human cells.
› Verified 2 days ago
News Archive
Biologists at New York University have uncovered one way that biological clocks control neuronal activity - a discovery that sheds new light on sleep-wake cycles and offers potential new directions for research into therapies to address sleep disorders and jetlag.
Research scientists will develop "Facebook Light" - with a user interface suitable for the elderly and people with dementia - to promote important social contact.
A new study, VERIFY (Vildagliptin Efficacy in combination with metfoRmIn For earlY treatment of type 2 diabetes) presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Barcelona, Spain (16-20 Sept, 2019), and published simultaneously in The Lancet, is the first to show that early combination therapy using vildagliptin and metformin in patients newly diagnosed with type 2 diabetes (T2D) leads to better long-term blood sugar control and a reduced rate of treatment failure than metformin alone.
Researchers from the Molecular Biology Institute of Barcelona and the Institute of Biotechnology and Biomedicine have discovered the mechanism by which the bacterium Mycoplasma genitalium) adheres to human cells.
› Verified 2 days ago
Richard Joseph Md Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 548 Market St # 50727, San Francisco, CA 94104 Phone: 415-851-3224 | |
James Y.greenberg, Md, A Professional Corporation Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2299 Post St Ste 205, San Francisco, CA 94115 Phone: 415-474-7955 Fax: 415-292-0718 | |
Inpatient Services Of California, Inc., A Medical Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3555 Cesar Chavez St, San Francisco, CA 94110 Phone: 415-641-6401 | |
Jew & Jew Medical Associates Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 919 Clay St, San Francisco, CA 94108 Phone: 415-982-4011 Fax: 415-982-6291 | |
Hampton Health Ltd Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1700 California St, Ste. 470, San Francisco, CA 94109 Phone: 415-202-9990 Fax: 415-843-0548 | |
North East Medical Services-leland Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 82 Leland Avenue, San Francisco, CA 94134 Phone: 415-391-9686 Fax: 415-333-9067 | |
Mission Area Health Associates Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1580 Valencia St Ste 506, San Francisco, CA 94110 Phone: 415-852-4080 Fax: 415-431-3178 |